Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer.
Rogmans C, Kuhlmann JD, Hugendieck G, Link T, Arnold N, Weimer JP, Flörkemeier I, Rambow AC, Lieb W, Maass N, Bauerschlag DO, Hedemann N. Rogmans C, et al. Among authors: kuhlmann jd. Cancers (Basel). 2021 Nov 6;13(21):5563. doi: 10.3390/cancers13215563. Cancers (Basel). 2021. PMID: 34771725 Free PMC article.
Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression.
Link T, Kuithan F, Ehninger A, Kuhlmann JD, Kramer M, Werner A, Gatzweiler A, Richter B, Ehninger G, Baretton G, Bachmann M, Wimberger P, Friedrich K. Link T, et al. Among authors: kuhlmann jd. Oncotarget. 2017 Apr 29;8(33):54592-54603. doi: 10.18632/oncotarget.17523. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903367 Free PMC article.
Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer.
Link T, Kuhlmann JD, Kobelt D, Herrmann P, Vassileva YD, Kramer M, Frank K, Göckenjan M, Wimberger P, Stein U. Link T, et al. Among authors: kuhlmann jd. Mol Oncol. 2019 May;13(5):1268-1279. doi: 10.1002/1878-0261.12484. Epub 2019 Apr 15. Mol Oncol. 2019. PMID: 30927479 Free PMC article. Clinical Trial.
Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients.
Göbel A, Kuhlmann JD, Link T, Wimberger P, Link-Rachner C, Thiele S, Dell'Endice S, Furesi G, Breining D, Rauner M, Hofbauer LC, Rachner TD. Göbel A, et al. Among authors: kuhlmann jd. J Bone Oncol. 2019 Apr 4;16:100237. doi: 10.1016/j.jbo.2019.100237. eCollection 2019 Jun. J Bone Oncol. 2019. PMID: 31011525 Free PMC article.
61 results